Sofinnova Partners exceeds target with €165M Biotech Acceleration Fund, Europe’s largest, with strong Pharma support Read more
Sofinnova Partners launches Biovelocita, the first pan-European investment strategy dedicated to the creation and acceleration of biotech startups Read more
Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France Read more